Updated Evaluation of Agalsidase Alfa Enzyme Replacement Therapy for Patients with Fabry Disease: Insights from Real-World Data

Sandro Feriozzi,1 Cristina Chimenti,2 Ricardo Claudio Reisin3 1Department of Nephrology and Dialysis Unit, Belcolle Hospital Viterbo, Italy; 2Department of Clinical Sciences, Internal Medicine, Anesthesiology and Cardiovascular Sciences, La Sapienza University, Rome, Italy; 3Department of Neurology,...

وصف كامل

التفاصيل البيبلوغرافية
المؤلفون الرئيسيون: Feriozzi S, Chimenti C, Reisin RC
التنسيق: مقال
اللغة:English
منشور في: Dove Medical Press 2024-04-01
سلاسل:Drug Design, Development and Therapy
الموضوعات:
الوصول للمادة أونلاين:https://www.dovepress.com/updated-evaluation-of-agalsidase-alfa-enzyme-replacement-therapy-for-p-peer-reviewed-fulltext-article-DDDT